Optimal immunological homoeostasis determines the long-term recovery of patients in the postoperative period. The functional adaptability of monocytes plays a pivotal role in adjusting the host's response to an insult, immunostasis and long-term health, and may help to determine successful recovery. We undertook a longitudinal analysis of the functional adaptability of monocytes in 20 patients undergoing heart surgery with cardiopulmonary bypass, as a model of severe stress. Using each patient's pre-cardiopulmonary bypass data as a baseline, we investigated the characteristics of peripheral blood monocytes' functional plasticity in-vitro before elective bypass, and three months afterwards. Approximately 30% of subjects showed diminished monocyte plasticity, as demonstrated by decreased monocyte differentiation into dendritic cells three months after bypass. Diminished monocyte functional plasticity was related to over-production of macrophage colony-stimulating factor. Adding a neutralising antibody to macrophage colony-stimulating factor corrected the monocytes' differentiation defect. Finally, patients with reduced monocyte plasticity had significantly elevated serum C-reactive protein, with a concomitant increase in cytomegalovirus IgG antibody titres, suggestive of the acquisition of immuno-suppressive traits. Our study shows that severe surgical stress resulted in a lasting immunological defect in individuals who had seemingly recovered.
Introduction
An aberrant inflammatory response is a significant cause of morbidity and mortality following a critical insult or surgery [1] . The emergence of a new immunological equilibrium following a critical insult has been proposed as the underlying cause of progressive organ failure, hastened atherosclerosis and resurgence of opportunistic infections [1] [2] [3] [4] [5] [6] [7] . It is uncertain whether postoperative immunological responses to subsequent challenges over an extended period of time are generalisable to all patients [2, [8] [9] [10] . Progress in this area has been limited, due to a focus on: short-term outcomes; large-scale population studies; static measurements of immune function with pre-insult assessment; lack of good animal models; and patient heterogeneity [1, 8] .
Although several leucocyte populations are essential for recovery following a critical insult or after cardiopulmonary bypass, there has been a particular focus on monocytes [2] [3] [4] 11] . The responsiveness of monocytes to pathogens and danger-associated signals is a pivotal part of the immunological response to an insult [3, 4, 9, 10] . During stress, monocytes develop into specialised populations, due to their inherited functional plasticity [11, 12] . Most importantly, they are a source of dendritic cells, which are crucial to the control of the immune response [13] . Loss of monocyte functional plasticity, heralded by a decreased ability of monocytes to become dendritic cells, signifies an abnormal immune response and is linked to unfavourable outcomes after trauma, pneumonia and cardiac surgery [3, 4, 6, 7, 11, [14] [15] [16] [17] . Thus, monocyte plasticity is significant, and pivotal to the immune response and maintenance of homoeostasis. The local cytokine milieu is influential when it comes to monocyte plasticity. Macrophage colony-stimulating factor (M-CSF), interleukin (IL)-6, and IL-10 are suppressive, whereas IL-4 and granulocyte monocyte colony-stimulating factor (GM-CSF) are supportive of dendritic cell differentiation from monocytes in in-vitro studies [12] [13] [14] .
We wished to characterise the duration of postbypass monocyte function after the resolution of an acute stress response. We measured the diminished ability of monocytes to become immature dendritic cells, since this process is critical for overall regulation of the immune system. Studies involving trauma victims and patients with sepsis have shown that one-third of affected individuals show persistent production of M-CSF, which prevents monocytes from differentiating into dendritic cells; this is linked to unfavourable clinical outcomes [1, 3, [8] [9] [10] 14] . We hypothesised that a similar proportion of patients would develop similar monocyte pathology following bypass, which has not previously been studied. Determination of patients' preoperative baseline status, and a clear insult in the form of cardiac surgery and bypass would help to address the limitations of previous studies [1, 3, [8] [9] [10] 14] .
Methods
The study was approved by the Institutional Review Board at the University of Pennsylvania (Philadelphia, PA), and performed in accordance with the ethical standards of the Declaration of Helsinki and it's later amendments. Written consent was obtained from all individuals enrolled in the study.
We initially enrolled a total of 22 patients scheduled for non-emergent coronary artery bypass grafting with the employment of bypass, between February 2014 and May 2015. We used a Terumo System 1 (Terumo Cardiovascular Group, Ann Arbor, MI, USA) equipped with a Sorin 3T cooler, a Terumo RX25E as an oxygenator and CAPIOX CP50 as a cardioplegia heat exchanger. Patients with actively treated disorders of the immune system (e.g. cancer, active autoimmune or rheumatologic disorders, and post-organ transplant) were not studied if they were treated with immunomodulatory medications. Two patients taking steroids chronically (for chronic obstructive pulmonary disease) were excluded from the study after enrolment after we established a full medical history. All subjects received a standardised peri-operative protocol, which included statins and aspirin, but prohibited the use of intravenous non-steroidal anti-inflammatory drugs. This was a hospital-wide protocol, with a compliance rate > 95%. Patients were matched with respect to age and sex with healthy controls (n = 23) to ensure technical accuracy [14, 18] .
We studied the subjects twice. Blood (30 ml) was collected before bypass (t 0 ) and long-term at three months (t +3m ) after surgery. These time-points were chosen to represent the immune system at baseline, and after the resolution of the acute stress response. At these two time-points, monocytes obtained from the subjects were incubated for five days in vitro with IL-4 and GM-CSF, and the frequency of CD1a + (a dendritic cell marker) cells was measured as a marker of the effectiveness of differentiation of monocytes into immature dendritic cell plasticity [14, 18] . Serum was stored. Mononuclear cells were separated using the Ficoll gradient technique, followed by the use of DynalBeads â (Life Technologies; Grand Island, NY) for the negative selection of monocytes [18] . Cell purity was > 80% CD14 (+) CD33 (+++) in a non-gated mixture of isolated cells, as assessed by flow cytometry. The generation of immature dendritic cells has been described previously [18] . Briefly, we incubated fresh monocytes with human IL-4 (500 IU.ml À1 ; Peprotech, Rocky Hill, NJ) and human GM-CSF (1000 IU.ml
À1
; Peprotech) at 37°C and 5% CO 2 . After 5 days, the cells were collected [14, 18] . In some experiments, the rabbit polyclonal neutralising antibody for M-CSF (FN M-CSF, 5 lg.ml À1 ) was added at the beginning, at a previously established concentration. The degree of monocyte to immature dendritic cell differentiation, a hallmark of monocyte plasticity, was assessed by the expression of immature dendritic cell markers like CD1a, CD83 and CD209 [18] . We also measured the ability of differentiated monocytes (with IL-4 + GM-CSF) to stimulate T-cells, and the production of IL12p70, a functional measurement of immature dendritic cell emergence, as previously described [18] . We incubated cells (10 5 ) with FACS media (phosphate-buffered saline with 0.01% sodium azide and 1% foetal bovine serum), which was enriched with human TrueStainFcX TM (BioLegend; San Diego, CA, USA), for 15 min at 4°C in the dark. Afterwards, we incubated the cells with antibodies for 15 min at 4°C in the dark. Cells were then washed twice in FACS media, and resuspended in 100 ll of 1% FlowFix (Polysciences; Warrington, PA, USA). We performed flow cytometry with an LSR TM (BD; San Jose, CA, USA) or FACSCalibur TM (BD) maintained by the Penn Core Facility. The cells were gated based on their autofluorescence background, after incubation with non-selective, appropriate, fluorescent control immunoglobulins. At least 10 4 cells were collected for each assessment [18] . The following antibodies were used: CD1a (HI149, BioLegend); CD14 (Tuk4, Invitrogen, Grand Island, NY); CD83 (HB15e, BD); CD116 (4H1, BioLegend); CD115 (AFS98, BioLegend); CD124 (G077F6, BioLegend); CD126 (UV4, BioLegend); CD206 (15-2, BioLegend); and CD116 (4H1, BioLegend). The frequency of naturally occurring dentritic cells was also analysed by staining mononuclear cells with the BDCA-3 antibody (Myltenyi Biotec, Germany) [19] .
We have reported the data as a proportion of positive cells (%) or as receptor density on the cell surface-mean fluorescent intensity (MFI).
We measured supernatant levels of cytokines (tumour necrosis factor TNFa; IL-6; IL-12p70; IL-15; and M-CSF) and serum concentrations of inflammatory markers (C-reactive protein [CRP]) using a magnetic multiplex kit (Bio-Rad, Hercules, CA, USA), as per the manufacturer's protocol, and analysed on the BioRad TM platform (Bio-Rad).
Enzyme-linked immunosorbent assays were performed for cytomegalovirus (CMV) IgG antibody (Abcam, Cambridge, UK), and aCMV IgM (Abcam), according to the manufacturers' protocols. Absorbance was measured using the Opsys MR with Revelation software.
The primary outcome measure of the study was the ability of monocytes to become dendritic cells under the influence of IL-4 + GM-CSF in-vitro. We used our prior work to undertake a power calculation [14, 18] . Taking into account the frequency of CD1a-positive cells after culturing monocytes obtained from healthy volunteers with IL-4 + GM-CSF (approximately 60%), and the 30% of trauma patients that showed severely depressed emergence of CD1a marker (20%), we needed to enrol 11 subjects to achieve a power of 0.9 (a = 0.05). Considering the pilot nature of this study, as well as our available funding, we decided to enrol a total of 20 patients into the study. We considered measuring more clinically relevant outcomes (e.g. pneumonia, sepsis), but would have had to enrol > 100 subjects in order to achieve sufficient statistical power. We considered this premature, since this research project was designed as a pilot study.
Most comparisons were done through longitudinal analysis using the patient's pre-bypass values (t 0 ) as the baseline, unless otherwise specified. We confirmed the parametric nature of the data by Levene and Shapiro-Wilk tests, and performed t-tests and Wilcoxon matched pair tests, depending on data characteristics. We undertook ANOVA testing for multiple-group longitudinal comparisons, with a posthoc Bonferroni test. We considered a p value < 0.05 to be statistically significant, unless otherwise specified. We analysed all data using Statistica v8.0 (Statistica, Tulsa, OK).
Results
Fifty-five per cent of our subjects were men. The mean (SD) age was 68.8 (13.4) years, and BMI 29.2 (5.3) kg.m
À2
. Table 1 shows the baseline and clinical characteristics, divided according to their monocyte performance. We identified two groups of patients by analysing the data at three months (t+3m), with respect to the baseline ability of each patient's monocytes to differentiate into immature dendritic cells. Most patients had unchanged, or even enhanced, differentiation of monocytes into immature dendritic cells, as evidenced by an increased frequency of CD1a-positive cells in IL-4 + GM-CSF-differentiated monocytes in vitro (Fig. 1a and b) . These patients were referred to as 'immunocompetent/CD1a (+) ' [14] . More importantly, approximately 30% of patients showed a diminished ability of monocytes to differentiate into immature dendritic cells t +3m after bypass (p = 0.001) (Fig. 1a and b) . These patients were referred to as 'immunodeficient/ CD1a (À) ', as previously indicated. At the same time, the production of IL-15 and IL-12p70, and the ability to stimulate T cells, was reduced in the post-bypass immunodeficient/CD1a (-) group (Table 2 The loss of the ability of immunodeficient/CD1a (À) monocytes to become immature dendritic cells could be due to the abnormal expression of cytokine receptors critical to monocyte differentiation [12] [13] [14] . However, there was no difference in the proportion of IL-4R-, GM-CSFR-, M-CSFR-and IL-6R-positive cells in monocytes at t +3m. (data not shown). Alternatively, patients whose monocytes cannot differentiate into dendritic cells may exhibit an exaggerated production of cytokines preventing monocytes from becoming dendritic cells, thus limiting their functional plasticity. Significantly elevated levels of M-CSF in the supernatant were observed after three days in culture (Table 3 ). TNFa and IL-10 were expressed at low levels or were undetectable (data not shown). Concomitantly, expression of M-CSF inducible marker CD206 (macrophage marker) was present at the highest levels in peripheral blood monocytes in patients whose monocytes showed diminished monocyte differentiation into immature dendritic cells under the influence of IL-4 and GM-CSf in vitro (MFI % CD206 
Pt+3m CD1a(-) = 3443.8 (932.3); p = 0.022) [20, 21] . Consequently, we (Fig. 1d) , production of IL-12p70 and IL-15, and T-cell proliferation (data not shown). A non-specific immunoglobulin had no effect on differentiation either (%CD1a IL-4 + GM-CSF = 43.5 (20.21)%, CD1a IL-4 + GM-CSF&IgG = 56.5(23.94) %).
Our study was powered to measure the difference in CD1a expression, based on preliminary data in trauma and cardiac surgery patients [14, 22] . The potentially significant clinical implications of our study would suggest an analysis of clinical outcomes, but the low incidence of co-morbidities (e.g. pneumonia, sepsis), and pilot nature of this study redirected our attention to the surrogate markers of poor clinical outcomes following bypass [23] . The emergence of opportunistic infection, as assessed by cytomegalovirus (CMV) titres, is seen in patients with poor recovery following critical insults, and is considered a surrogate of clinically relevant immunosuppression. We found that immunodeficient patients had elevated titres of antibodies (IgG) against cytomegalovirus (aCMV IgG) (Fig. 2a) . However, their titres of aCMV IgM antibodies were not elevated (data not shown), suggesting resurgence of a preexisting infection. Furthermore, CRP is frequently linked to accelerated atherosclerosis and the presence of ongoing inflammation. Serum levels of CRP remained significantly elevated at t +3m immunodeficient/CD1a (À) patients when compared with patients without monocyte differentiation deficits (Fig. 2b) .
Discussion
Here, we have shown for the first time that elective cardiac surgery could trigger a loss in monocyte plasticity after three months in some subjects, with a concomitant decline in markers of immunosuppression (aCMV IgG), chronic inflammation/atherosclerosis (CRP), and accelerated atherosclerosis (aCMV IgG, CRP) [23] [24] [25] [26] [27] . Previously studies did not follow up subjects for longer than one month, nor did they account for patients' immune status before the insult [22, 28, 29] . We have also shown that an in-vivo defect is accompanied by long-term decline in endogenous dendritic cell numbers (BDCA-3 (+) ) [19] . Similar declines were seen in patients with heart failure and other chronic conditions, but not in surgical populations [5, 14, 15] . Therefore, we may conclude that, in certain individuals, a severe insult to the immune system may result in the development of aberrant immunostasis, which potentially leads to an unfavourable health status [1, 30] . Some studies have shown that monocyte responses depend on the individual, as some patients may be 'poor responders' [2, 9, 10, 16, 20] . An interesting implication of our findings is that it may in the future be possible to identify susceptible individuals. Implementation of individually tailored therapy could then be instituted, potentially avoiding unfavourable outcomes.
It is unclear what determines the emergence of post-insult immunostasis [1, 30] . In this study, we assessed the plasticity of monocytes before and after the insult, which allowed us to account for each patient's individual characteristics. The ability of monocytes to become dendritic cells has been shown to be highly variable between individuals, but stable over time [18] . We did not find any difference in baseline characteristics between patients and healthy controls, but our sample size does not allow us to draw any conclusions. Overall, the observed long-term decline in the developmental plasticity of monocytes was most likely secondary to the stress related to the peri-operative period itself. Whether the observed effect is a result of anaesthesia, surgery or CPB remains unknown. Some have suggested that surgery, and not bypass itself, is the primary trigger [31] [32] [33] [34] . We believe that our study demonstrates that any severe insult to a host will result in aberrant and lasting immunostasis in susceptible patients. Mechanistically, this concept is similar to susceptible individuals developing the systemic inflammatory response syndrome (SIRS) after an insult. Identification of these patients may be critical for their recovery, and to the future role of anaesthesiologists as peri-operative physicians.
We showed that M-CSF production was responsible for the decrease in the development of monocyte plasticity. The secretion of M-CSF was elevated in subjects with poor monocyte to immature dendritic cell conversion. M-CSF-induced marker CD206 was elevated. Interestingly, M-CSF secretion is supported by a positive feedback loop, that allows for M-CSF production even after the triggering stimulus has subsided [14, 20, 21] . Disruption of this positive feedback loop by an antibody that neutralised M-CSF resulted in restoration of monocyte functional plasticity, but only in affected subjects. This new observation shows that only certain individuals will respond to treatment. Elevated secretion of M-CSF is most likely a result of an exaggerated response to a stimulus (like CPB in our study) and/or a lack of M-CSF homoeostasis [3, 9, 14, 17] . De et al. characterised a very similar mechanism for loss of monocyte plasticity in the trauma population [14] . Epigenetic changes in the M-CSF promoter region, or persistent activation of inflammatory kinases are a promising mechanism as they can be sustained, Figure 2 Serum concentration of aCMV IgG and Creactive protein, surrogates of poor clinical outcomes, showed significant increases in immunodeficient patients 3 months after surgery. Control group (grey), and baseline (black); immunocompetent group (sand), and immunodeficient group (checkers). Error bars indicate SD. **p < 0.01; ***p < 0.001 even after the initial insult is over [35, 36] . However, using more in-depth research methodology (gene activation analysis) could determine other persistently activated pathways [16, 29, 30] .
Exaggerated production of M-CSF results in accelerated atherosclerosis and immunoparesis, potentially contributing to a decline in postoperative health [4, 15, 20, 21] . Our study shows that the identification of subjects whose monocyte plasticity is diminished as a result of M-CSF, may allow for precise targeting of affected molecular pathways in patients with a high probability of unfavourable long-term postoperative outcomes. Theoretically, such patients could be identified and targeted for enhanced peri-operative care to alleviate postoperative complications. The infrequent occurrence of relevant outcomes (sepsis, pneumonia) and pilot nature of the study precluded us from drawing any conclusion linking patient characteristics, unfavourable clinical outcome and type of patients' response to bypass.
Monocyte-derived dendritic cells play an important role in controlling both innate and acquired immunity [6, 12, 13, 37] . The aberrant process of monocyte to immature dendritic cell differentiation has been shown to result in a prolonged inflammatory process, accelerated atherosclerosis, cancer recurrence, resurgence of opportunistic infection (like cytomegalovirus) and progressive organ failure [3-5, 7, 11, 14, 15, 37] . However, these effects are frequently delayed, and our study was not designed to investigate the emergence of such prolonged processes. We also studied a relatively healthy population, and most of our patients would have recovered without complications. A much larger sample size (> 100 subjects) would have been required to detect evidence of important clinical outcomes such as pneumonia, and was not feasible, given the nature of our pilot study. We therefore measured several surrogates of an incompetent immune response in individuals with a monocyte to immature dendritic cell differentiation defect at t +3m . Most notably, we observed increased serum CRP levels [25] . CRP is an acute-phase protein that is frequently seen in persistent inflammation. It is also used to stratify the risk of cardiovascular disease [25] . Persistent elevation of CRP may result in accelerated atherosclerosis in immunodeficient/CD1a (À) patients.
In addition, we noticed an elevation in aCMV IgG titres. CMV is considered to be a latent infection, and an increased titre of CMV is linked to immunosuppression, and poor outcomes after cardiac surgery [24, 27] . Our study thus shows that there are elevated levels of biomarkers linked to significant, unfavourable negative outcomes. This study has several limitations. Firstly, it was intended to be an observational study; no in vivo interventions were conducted. The sample size of 20 patients was relatively small, and any clinically relevant outcome could not be appropriately measured, since the primary outcome measure of our study was the ability of monocytes to become dendritic cells in vitro. Patients with depressed monocyte plasticity appeared to receive more blood transfusions, although the difference was not statistically significant. We cannot exclude the influence of peri-operative medical regimens, most notably statin dosing. Our study was not designed to investigate the effects of bypass, cardiac surgery or peri-operative stressors themselves [1, 8, 30, 33, 34] . The main strength of this study is its longitudinal design, which reduced inter-patient variability, and significantly increased statistical power. Other strengths include the relative uniformity of the offending insult, and the pharmacological regimen post-bypass, as well as the presence of preinsult immunological characteristics.
Overall, we observed the emergence of a newly acquired in-vitro defect in the plasticity of peripheral blood monocytes in 30% of patients undergoing elective cardiac surgery with bypass. In the affected subjects, this defect was reversible by the addition of a neutralising antibody for M-CSF, providing a theoretical target for drug-based interventions. We believe that a similar defect may be observed in the non-specific response to an overwhelming peri-operative insult in susceptible individuals. Our study suggests that the responses of patients to peri-operative stress may be insidious, and have a delayed effect in certain individuals. Identification of such susceptible subjects would be important to aiding long-term recovery in patients undergoing major surgery. These findings may be potentially important for anaesthetists when predicting patients' postoperative recovery, and for risk-stratifying patients for the potential development of long-term unfavourable outcomes.
